| |
| |
|
| Insider
Information: |
Wellington Biomedical Innovation Master Investors |
| Relationship: |
|
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
17,641,001 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$53,086,329 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
17,641,001 |
|
|
| Total
Value |
$53,086,329 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Black Diamond Therapeutics, Inc. |
BDTX |
10% Owner |
2020-02-03 |
568,185 |
2020-02-03 |
0 |
Premium* |
|
|
Generation Bio Co. |
GBIO |
10% Owner |
2020-06-16 |
2,112,546 |
2020-06-16 |
0 |
Premium* |
|
|
Forma Therapeutics Holdings, Inc., |
FMTX |
10% Owner |
2020-06-23 |
2,252,913 |
2020-06-23 |
0 |
Premium* |
|
|
Nurix Therapeutics, Inc. |
NRIX |
10% Owner |
2020-07-28 |
784,313 |
2020-07-28 |
0 |
Premium* |
|
|
Kymera Therapeutics, Inc. |
KYMR |
10% Owner |
2020-08-25 |
959,211 |
2020-08-25 |
0 |
Premium* |
|
|
Dyne Therapeutics, Inc. |
DYN |
10% Owner |
2020-09-21 |
1,608,785 |
2020-09-21 |
0 |
Premium* |
|
|
Pmv Pharmaceuticals, Inc. |
PMVP |
Former 10% Owner |
2020-09-29 |
760,267 |
2020-09-29 |
0 |
Premium* |
|
|
Aligos Therapeutics, Inc. |
ALGS |
10% Owner |
2020-10-20 |
1,906,191 |
2020-10-20 |
0 |
Premium* |
|
|
Olema Pharmaceuticals, Inc. |
OLMA |
10% Owner |
2020-11-23 |
1,725,406 |
2020-11-23 |
0 |
Premium* |
|
|
Edgewise Therapeutics, Inc. |
EWTX |
10% Owner |
2021-03-30 |
681,812 |
2021-03-30 |
0 |
Premium* |
|
|
Verve Therapeutics, Inc. |
VERV |
10% Owner |
2021-06-21 |
2,495,571 |
2021-06-21 |
0 |
Premium* |
|
|
Nuvalent, Inc. |
NUVL |
10% Owner |
2021-08-02 |
897,671 |
2021-08-02 |
0 |
Premium* |
|
|
Acrivon Therapeutics, Inc. |
ACRV |
|
2022-11-17 |
888,130 |
2022-11-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACRV |
Acrivon Therapeutics, Inc... |
|
– – • |
2022-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
888,130 |
888,130 |
0 |
- |
|
| NUVL |
Nuvalent, Inc. |
10% Owner |
– – • |
2021-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
897,671 |
897,671 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
10% Owner |
– – • |
2021-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,495,571 |
2,495,571 |
0 |
- |
|
| EWTX |
Edgewise Therapeutics, In... |
10% Owner |
– – • |
2021-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
681,812 |
681,812 |
0 |
- |
|
| OLMA |
Olema Pharmaceuticals, In... |
10% Owner |
– – • |
2020-11-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,725,406 |
1,725,406 |
0 |
- |
|
| ALGS |
Aligos Therapeutics, Inc. |
10% Owner |
– – • |
2020-10-20 |
4 |
A |
$0.00 |
$0 |
D/D |
1,906,191 |
1,906,191 |
0 |
- |
|
| PMVP |
Pmv Pharmaceuticals, Inc. |
Former 10% Owner |
– – – |
2020-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
760,267 |
760,267 |
0 |
- |
|
| DYN |
Dyne Therapeutics, Inc. |
10% Owner |
– – • |
2020-09-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,608,785 |
1,608,785 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
10% Owner |
– – • |
2020-08-25 |
4 |
A |
$0.00 |
$0 |
D/D |
959,211 |
959,211 |
0 |
- |
|
| NRIX |
Nurix Therapeutics, Inc. |
10% Owner |
– – • |
2020-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
784,313 |
784,313 |
0 |
- |
|
| FMTX |
Forma Therapeutics Holdin... |
10% Owner |
– – • |
2020-06-23 |
4 |
B |
$20.00 |
$20,000,000 |
D/D |
1,000,000 |
2,252,913 |
2.45 |
- |
|
| FMTX |
Forma Therapeutics Holdin... |
10% Owner |
– – • |
2020-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,252,913 |
1,252,913 |
0 |
- |
|
| GBIO |
Generation Bio Co. |
10% Owner |
– – • |
2020-06-16 |
4 |
B |
$19.00 |
$20,900,000 |
D/D |
1,100,000 |
2,112,546 |
2.45 |
- |
|
| GBIO |
Generation Bio Co. |
10% Owner |
– – • |
2020-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,012,546 |
1,012,546 |
0 |
- |
|
| BDTX |
Black Diamond Therapeutic... |
10% Owner |
– – • |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
568,185 |
568,185 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
